Cough News and Research

RSS

SARS-CoV-2 Omicron variant tends to spread more easily among children than prior strains

Researchers estimate the age-varying susceptibility to infection with the SARS-CoV-2 Omicron variant.

28 Nov 2022

Long COVID brain fog and fatigue negatively impact all facets of daily life

In a recent study published in the International Journal of Environmental Research and Public Health, researchers explored the lived experiences of individuals with post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC) to understand the impact of the symptoms such as fatigue and brain fog on the various aspects of life including employment, daily activities, and interpersonal relationships.

27 Nov 2022

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

James Smyth, associate professor at the Fralin Biomedical Research Institute at VTC, has been awarded a five-year, $2.7 million grant from the National Institutes of Health to discover why viruses that normally infect our lungs can turn deadly when they infect the heart.

23 Nov 2022

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks.

22 Nov 2022

The WHO announces four MERS cases from Saudi Arabia in recent weeks

A recent disease outbreak alert released by the World Health Organization (WHO) reported four laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) from three regions in the Kingdom of Saudi Arabia.

21 Nov 2022

Frozen and viable: successful culture of replicating SARS-CoV-2 from hospital aerosol samples after freezing

Researchers demonstrated the presence of infectious SARS-CoV-2 in samples from the hospital rooms of SARS-CoV-2-infected patients.

21 Nov 2022

Study identifies risk factors and symptom clusters associated with long-COVID

A recent study posted to medRxiv* preprint server evaluated risk factors associated with long COVID.

17 Nov 2022

Experts highlight the need to study and develop treatments for fungal infections

Fungi in the soil cause a significant number of serious lung infections in 48 out of 50 states and the District of Columbia, including many areas long thought to be free of deadly environmental fungi, according to a study by researchers at Washington University School of Medicine in St. Louis.

17 Nov 2022

Smoking marijuana damages the lungs more than tobacco

Lungs of marijuana smokers exhibit greater levels of airway inflammatory markers and emphysema as compared to those of tobacco-only smokers.

15 Nov 2022

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Researchers examined the prevalence of changes in liver enzymes in COVID-19.

15 Nov 2022

One in four people with COPD waited more than five years for a diagnosis, research reveals

Asthma + Lung UK is calling for lung health to become an urgent priority after a damning report, released ahead of World COPD Day tomorrow, reveals that almost a quarter1 of people surveyed with the deadly lung disease chronic obstructive pulmonary disease (COPD), waited more than five years for a diagnosis, whilst one in eight waited more than a decade.

15 Nov 2022

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Researchers investigated coronavirus disease 2019 (COVID-19)-associated morbidity in children, adolescents, and adults using healthcare data covering ~46% of the German population.

14 Nov 2022

Analysis reveals highest number of pneumonia deaths in the UK

More people die from pneumonia in the UK than anywhere else in Europe, according to new analysis by leading lung charity, Asthma + Lung UK. Now, the charity is raising awareness of the signs and symptoms of pneumonia, and urging people who are eligible, such as those with severe asthma, pulmonary fibrosis and COPD, to get their one-off pneumonia vaccine.

10 Nov 2022

Surge in RSV cases – how worried should you be?

RSV hospitalizations are reaching similarly high levels much earlier than normal this year.

10 Nov 2022

People of all age groups are at risk of post-COVID-19 syndrome, study says

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

10 Nov 2022

Evaluating dual direct-acting antivirals against persistent COVID-19

Researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19).

7 Nov 2022

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) COVID-19 patients for six months after laboratory-confirmed SARS-CoV-2 infections to identify factors that increase the risk of post-COVID-19 condition development in the South African population.

4 Nov 2022

Extensive European study finds very high rates of long-COVID

In a recent study published by the European Center for Disease Prevention and Control, researchers assessed the prevalence of post-coronavirus disease 2019 (COVID-19) condition symptoms.

1 Nov 2022

Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine

In a new study, researchers assessed the immunogenicity and safety of KD-414, an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

Cough News and Research

SARS-CoV-2 Omicron variant tends to spread more easily among children than prior strains

Long COVID brain fog and fatigue negatively impact all facets of daily life

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

The WHO announces four MERS cases from Saudi Arabia in recent weeks

Frozen and viable: successful culture of replicating SARS-CoV-2 from hospital aerosol samples after freezing

Study identifies risk factors and symptom clusters associated with long-COVID

Experts highlight the need to study and develop treatments for fungal infections

Smoking marijuana damages the lungs more than tobacco

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

One in four people with COPD waited more than five years for a diagnosis, research reveals

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Analysis reveals highest number of pneumonia deaths in the UK

Surge in RSV cases – how worried should you be?

People of all age groups are at risk of post-COVID-19 syndrome, study says

Evaluating dual direct-acting antivirals against persistent COVID-19

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Extensive European study finds very high rates of long-COVID

Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine

Cohort study determines how often COVID-19 symptoms recurred

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News